Skip to main content
. 2022 Feb 16;113(4):1441–1450. doi: 10.1111/cas.15286

TABLE 2.

Impact of alcohol intake on pancreatic cancer risk and assessment of variant‐drinking interaction

Analysis HERPACC‐2 (2001‐2005) HERPACC‐3 (2005‐2013) Pooled analysis
OR a 95% CI P value OR a 95% CI P value OR a 95% CI P value
Alcohol intake (g/d)
0 ref ref ref
<23 1.16 0.73 1.86 0.532 0.81 0.54 1.22 0.321 0.99 0.73 1.34 0.953
<46 1.27 0.67 2.39 0.460 1.22 0.69 2.15 0.502 1.26 0.83 1.90 0.283
≥46 1.34 0.65 2.77 0.433 1.75 0.97 3.17 0.065 1.57 1.00 2.46 0.050
Trend (per 10 g/d) 1.05 0.99 1.12 0.074 1.06 1.00 1.12 0.042 1.05 1.01 1.10 0.011
Interaction analyses b
Additive interaction 0.067 −0.076 0.209 0.360 0.046 −0.088 0.179 0.501 0.068 −0.027 0.164 0.161
Multiplicative interaction 1.06 0.93 1.20 0.406 1.03 0.92 1.16 0.577 1.06 0.97 1.15 0.196

Estimates in bold show statistical significance (P < .05).

Abbreviations: ALDH2, aldehyde dehydrogenase 2; CI, confidence interval; HERPACC, Hospital‐based Epidemiologic Research Program at Aichi Cancer Center; OR, odds ratio.

a

ORs were calculated by a conditional logistic regression model adjusted for age, pack‐years, body mass index, meat intake, processed meat intake, family history of pancreatic cancer, history of diabetes, and ALDH2 rs671 genotype.

b

Multiplicative interaction was assessed using a Wald test of the coefficient of the interaction term corresponding to a one‐allele change in the genetic variant multiplied by a 10‐g change in daily alcohol intake; the test for additive interaction was carried out using the relative excess risk due to interaction.